Rose is a managing editor at The American Journal of Managed Care® (AJMC®).
She has a BA in journalism & media studies and Spanish from Rutgers University. You can connect with Rose on LinkedIn.
Trial Confirms Clinical Activity of Trametinib Plus Dabrafenib in BRAF-V600–Mutant Melanoma
September 24th 2021The largest known prospective study of patients treated with trametinib plus dabrafenib for unresectable advanced melanoma with BRAF-V600 mutation confirmed the combination’s clinical activity.
Read More
Study Clarifies Prevalence and Incidence of SMA in Japan
September 16th 2021An epidemiological investigation of spinal muscular atrophy (SMA) in Japan provided clarity on the genetic condition’s prevalence and incidence in the country and highlighted the importance of newborn screening for SMA
Read More
AJMC®TV interviews let you catch up on what’s new and important about changes in healthcare, with insights from key decision makers—from the clinician, to the health plan leader, to the regulator. When every minute in your day matters, AJMC®TV interviews keep you informed. Access the video clips at ajmc.com/interviews. These interviews have been edited lightly for clarity.
Read More
Insights on Small-Cell Lung Cancer NCCN Guidelines
April 4th 2021Kathryn Gold, MD, medical oncologist and associate professor of medicine at UC San Diego, who is a member of the NCCN guidelines panel for small-cell lung cancer, gives insight into the guidelines and the importance of frequent updates.
Read More
Management of Biliary Obstruction in Patients With Cholangiocarcinoma
April 1st 2021At the 2021 Cholangiocarcinoma Foundation Annual Conference, experts discussed guidelines and real-world data for the management of urgent symptoms in patients with cholangiocarcinoma who have biliary stents or drains.
Read More
Recent Advances and New Methodologies in Cholangiocarcinoma
March 31st 2021Discussions at the start of the 2021 Annual Cholangiocarcinoma Foundation Conference centered on challenges and advances made during the COVID-19 pandemic, and the potential of liver transplantation in cholangiocarcinoma.
Read More
Dr Al B. Benson on Neoadjuvant Treatment in Hepatobiliary Cancers
March 24th 2021Al B. Benson, MD, FACP, FASCO, professor of medicine and director for Cooperative Groups at the Robert H. Lurie Comprehensive Cancer Center, discusses the potential for neoadjuvant intervention in hepatobiliary cancers.
Read More
NCCN Panel Discusses Challenges, Potential Solutions for Racial Disparities in Cancer Care
March 20th 2021A keynote session at the NCCN Virtual Annual Conference brought a panel of patient advocates and experts together for a timely and necessary discussion about strategies to reduce racial disparities in oncology.
Read More
Benefits and Challenges of ePRO Implementation in Oncology
March 19th 2021During a session at the National Comprehensive Cancer Network (NCCN) annual virtual conference, the payer perspective and physician experiences with PRO systems in both the community and academic medical center settings took center stage.
Read More
Cancer Survivors Returning to Work: Barriers and Interventions
March 18th 2021Amye J. Tevaarwerk, MD, director of the Survivorship Program at the University of Wisconsin Carbone Cancer Center, discussed the impact that cancer diagnosis and treatment can have on survivors when it comes to work.
Read More